Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 274

1.

Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.

Hoenerhoff MJ, Shibata MA, Bode A, Green JE.

Transgenic Res. 2011 Apr;20(2):247-59. doi: 10.1007/s11248-010-9406-5. Epub 2010 Jun 12.

PMID:
20549348
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu ZY, Calvo A, Couldrey C.

Oncogene. 2000 Feb 21;19(8):1020-7. Review.

PMID:
10713685
[PubMed - indexed for MEDLINE]
Free Article
3.

p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.

Shibata MA, Maroulakou IG, Jorcyk CL, Gold LG, Ward JM, Green JE.

Cancer Res. 1996 Jul 1;56(13):2998-3003.

PMID:
8674054
[PubMed - indexed for MEDLINE]
Free Article
4.

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.

J Clin Invest. 2008 Jan;118(1):64-78.

PMID:
18079969
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.

Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R.

Cancer Res. 2001 Oct 15;61(20):7449-55.

PMID:
11606379
[PubMed - indexed for MEDLINE]
Free Article
6.

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

Maroulakou IG, Anver M, Garrett L, Green JE.

Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11236-40.

PMID:
7972041
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.

Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, Lonardi S, Arthur C, Young LJ, Levy DE, Welch MJ, Cardiff RD, Schreiber RD.

Breast Cancer Res. 2012 Jan 20;14(1):R16.

PMID:
22264274
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen transgenic mouse model.

Holzer RG, MacDougall C, Cortright G, Atwood K, Green JE, Jorcyk CL.

Breast Cancer Res Treat. 2003 Jan;77(1):65-76.

PMID:
12602905
[PubMed - indexed for MEDLINE]
9.

STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice.

Meyer-Losic F, Newman SP, Day JM, Reed MJ, Kasprzyk PG, Purohit A, Foster PA.

PLoS One. 2013 Dec 6;8(12):e80305. doi: 10.1371/journal.pone.0080305. eCollection 2013.

PMID:
24324595
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.

Shibata MA, Jorcyk CL, Liu ML, Yoshidome K, Gold LG, Green JE.

Toxicol Pathol. 1998 Jan-Feb;26(1):177-82. Review. No abstract available.

PMID:
9502400
[PubMed - indexed for MEDLINE]
Free Article
11.

Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.

Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee EY, Medina D, Shih JH, Green JE.

Cancer Res. 2007 Sep 1;67(17):8065-80. Erratum in: Cancer Res. 2007 Oct 15;67(20):10097.

PMID:
17804718
[PubMed - indexed for MEDLINE]
Free Article
12.

Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.

Zhu M, Yi M, Kim CH, Deng C, Li Y, Medina D, Stephens RM, Green JE.

Genome Biol. 2011 Aug 16;12(8):R77. doi: 10.1186/gb-2011-12-8-r77.

PMID:
21846369
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.

Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, Graessmann A.

Oncogene. 1998 Apr 23;16(16):2103-14.

PMID:
9572491
[PubMed - indexed for MEDLINE]
Free Article
15.

Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.

Hirner H, Günes C, Bischof J, Wolff S, Grothey A, Kühl M, Oswald F, Wegwitz F, Bösl MR, Trauzold A, Henne-Bruns D, Peifer C, Leithäuser F, Deppert W, Knippschild U.

PLoS One. 2012;7(1):e29709. doi: 10.1371/journal.pone.0029709. Epub 2012 Jan 3.

PMID:
22235331
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.

Franks SE, Campbell CI, Barnett EF, Siwicky MD, Livingstone J, Cory S, Moorehead RA.

Oncogene. 2012 Jul 5;31(27):3298-309. doi: 10.1038/onc.2011.486. Epub 2011 Oct 24.

PMID:
22020329
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.

Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.

Cell Growth Differ. 1995 Jun;6(6):737-48.

PMID:
7669729
[PubMed - indexed for MEDLINE]
Free Article
18.

Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.

Campbell MJ, Wollish WS, Lobo M, Esserman LJ.

In Vitro Cell Dev Biol Anim. 2002 Jun;38(6):326-33.

PMID:
12513120
[PubMed - indexed for MEDLINE]
19.

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

Cancer Res. 2006 May 1;66(9):4672-80.

PMID:
16651418
[PubMed - indexed for MEDLINE]
Free Article
20.

Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.

Wong AW, Dunlap SM, Holcomb VB, Nunez NP.

Alcohol Clin Exp Res. 2012 Apr;36(4):577-87. doi: 10.1111/j.1530-0277.2011.01654.x. Epub 2011 Oct 7.

PMID:
21981381
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk